Navigation Links
Long Term Care International Forum names LTCG's Pam Kreager as President
Date:11/11/2008

F President, and we are very proud of her for being recognized by her industry peers in this manner." LTCG CEO Bruce Baude added, "Pam embodies LTCG's values of respect for people, learning and competence. She's regarded as a true expert in her field and is a great example of the type of people we work hard to cultivate here at LTCG."

About Long Term Care Group, Inc. (LTCG)

LTCG is the insurance industry's leading provider of Long Term Care Insurance Administration, Claims and Underwriting Assessments; Clinical audits, and offers a robust suite of Actuarial, Product development and consulting services. LTCG is headquartered in Eden Prairie MN, with offices in Woodbury MN, Brooklyn Center MN, Carmel IN, Nashville TN, Maitland FL, Milwaukee WI, Natick MA and Los Angeles CA. For more information about LTCG contact Lane B. Kent, Senior Vice President of Sales & Marketing, lkent@ltcg.com, or visit their website at http://www.LTCG.com.


'/>"/>
SOURCE Long Term Care Group, Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related medicine news :

1. International Isotopes Inc. Announces Third Quarter and Nine Months 2008 Financial Results
2. U of T professor first Canadian woman to win prestigious international science prize
3. Chindex International Inc. Reports Second Quarter FY 2009 Financial Results
4. Health Care Workers Get Help Fighting Unprecedented Attacks from Service Employee International Union Leadership
5. Ceasefire Broken in Democratic Republic of Congo; International Medical Corps Warns of Looming Humanitarian Catastrophe and Wider Regional Impact
6. Easter Seals Elects Kent Schien, Chief Executive Officer of St. Louis-based Innoventor, to the Organizations International Board of Directors
7. Schiff(R) Nutrition International Declares November Give Thanks for Grandparents Month
8. DATATRAK International, Inc. Announces 2008 Third Quarter and Nine Month Operating Results
9. Joslin researcher named first winner of the Manpei Suzuki International Prize for Diabetes Research
10. Skinvisible Appoints Dr. Geert Cauwenbergh to Its International Advisory Board
11. EarthSearch Communications International Joins Motorola's Enterprise Mobility Business PartnerSelect Program

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)... grew out of a collaboration between UCLA engineer...he nearly 10 million Americans who suffer from per...rdening of the arteries, peripheral arterial disea...ch narrowed arteries reduce blood flow to the limb...ular disease, heart attack and stroke, and its pro...
(Date:11/25/2009)...too short to draw definite conclusions, experts sa...ws) -- In diabetic patients with blocked coronary ...comes at one year whether patients undergo bypass ...archers report. , Bypass surgery has been the s...ary artery disease. However, less invasive approac...
(Date:11/25/2009)...ation and treatment clinics to resume Monday, Nov....ovember 25, 2009 -- Centegra Health System is cont...ne shots at four Centegra Primary Care (CPC) vacci...as arrived. The clinics are at CPC sites in Huntle... open as follows: ,   From 4:30 to 7:3...
(Date:11/25/2009)...ological symptoms, study finds , , WEDN...de effects are among the potential problems faced ...re treated with cisplatin-based chemotherapy, a ne...orwegian men treated for unilateral testicular can...w-up survey conducted from 1998 to 2002. , The ...
(Date:11/25/2009)...re/-- MISSIONSkincare ®isproudtosupportGNC,se...NC,sannualSt.Jude ThanksandGiving campaign,$1fromt...ER-C(TM)LipBalm willbedonatedtoSt.Jude.Additionall...onationatcheckoutatoneoftheir5,000+retaillocations...Judeduringtheir2009 ThanksandGiving campaign. ,...
Breaking Medicine News(10 mins):Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 4Health News:Stenting May Equal Bypass for Diabetic Heart Patients 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 4Health News:MISSION Skincare(R) Supports GNC's Efforts To Raise Money for St. Jude Children's Research Hospital(R) 2
...y, contrast-enhanced sonography compared with sono...sessment of blunt abdominal trauma.// Massimo... objective of our study was to prospectively compa...ts”. The study was conducted by the departme...
...d about subject as sex is, perhaps vying with each...act of stress is well known - responsible //for ma...ecently stress during pregnancy was thought to lea...en seem to be twice inclined to suffer PSTD and de...
...ced that the deadly H5N1 strain of bird flu has be...ria, which is the first African// country to be hi...been reported, experts fear that several cases hav...es in Taraba, one commercial farm and two places w...
...c study says ‘significant fluctuations in the firs...ncreases// the chances of death’. According to...ying diastolic blood pressure, which again is root...24 hours. Blood pressures were checked every five ...
...nt of Energy's Pacific Northwest National Laborato...s that the damage in neurodegenerative diseases// ...led nitration. It was explained that Parkinson's, ...idative stress, the cell damage that is usually ca...
...els will sashay down the catwalk alongside eight b...s Assam city// . Preparations are on for the ...e ornate Pragjyoti cultural centre in Guwahati. Yo...ippanita Sharma for company that day. "The e...
Other Medicine News:Health News:New Tool Found to be Effective in Assessing Blunt Abdominal Trauma 2Health News:Fluctuating BP and Stroke Lowered Patient Survival Rate 2Health News:Scientist Optimistic In Breakthrough For Causes Of Neurodegenerative Diseases 2Health News:Blind Girl Students to Catwalk in Guwahati Fashion Show 2
(Date:11/25/2009)...--RegadoBiosciences,aprivatelyheldcompanyleadingth...rolagents,announcedthatDavidMazzo,PhD,CEOandPresid...lthCareConferenceattheNewYorkPalaceHotelinNewYorkC...onTuesday,December1andwillincludeanoverviewoftheCo...gram,theanticoagulantsystem,REG1.Thehealthcareindu...
(Date:11/25/2009).../--SwissrayInternational,Inc.aleadingmanufacturero...odaythatitsoperationshavebeenacquiredbyaprivateSwi...smedicalimagingbrand.Theacquisitionincludedallasse...ntory.After25yearsofsuccessandgrowthSwissrayisnowp...tswithstableandsteadygrowth. ,, "Swissrayhaslon...
(Date:11/25/2009)...nker.comannouncesthatanewmarketresearchreportisava...y-USMarketTrends&Analysis http://www.reportli...rket-Trends--Analysis.html ,, TheUSintranasald...ticapplicationsfromthedeliveryofconventionallocalt...rugs.Thefutureofthetechnologyhingesontotheeffectiv...
Breaking Medicine Technology:Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2Swissray International Announces New Ownership 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5Gamida Cell and Cellerix Partner on Feasibility Study 14558 1Gamida Cell and Cellerix Partner on Feasibility Study 14558 2Gamida Cell and Cellerix Partner on Feasibility Study 14558 3NASCSA Receives 24200 000 Grant From Purdue Pharma L P to Support State Prescription Drug Monitoring Programs 5633 1NASCSA Receives 24200 000 Grant From Purdue Pharma L P to Support State Prescription Drug Monitoring Programs 5633 2Shire Targets Fourth Quarter Filing of BLA for REPLAGAL 28R 29 for Fabry Disease With U S FDA 5629 1Shire Targets Fourth Quarter Filing of BLA for REPLAGAL 28R 29 for Fabry Disease With U S FDA 5629 2Shire Targets Fourth Quarter Filing of BLA for REPLAGAL 28R 29 for Fabry Disease With U S FDA 5629 3Shire Targets Fourth Quarter Filing of BLA for REPLAGAL 28R 29 for Fabry Disease With U S FDA 5629 4
...ed Parenteral Product Ganite(R), BERKELEY HEIGHTS...A ) today announced that the Company has received ...pharmaceutical gallium compositions,and complexes ... U.S.,Patent 7,354,952 extends the intellectual pr... gallium-containing products that are intended,as ...
...R Annual Meeting, SOMERSET, N.J., April 14 Alfac...hat Dr. Intae Lee with the University of,Pennsylva...ase) could be a,promising radiation sensitizer for...clinical in vivo and in vitro data in a poster at ...AACR) Annual Meeting being held April 12 -,16 in S...
Other Medicine Technology:Genta Receives Key Patent Related to Oral Gallium Compound G4544 2Genta Receives Key Patent Related to Oral Gallium Compound G4544 3Alfacell's ONCONASE(R) Shows Potential as Radiation Sensitizer for Lung Cancer Treatment 2Alfacell's ONCONASE(R) Shows Potential as Radiation Sensitizer for Lung Cancer Treatment 3
Pediatric Ureteral Catheters
Silicone Universal Drainage Stents
Double Pigtail Stent Sets - Polyurethane
Koyle Diaper Stents
Medicine Products: